Help us: Donate
Follow us on:
×

Repair Biotechnologies

Organization Description

 

Repair Biotechnologies develops the Cholesterol Degrading Platform (CDP), a first in class approach to therapy aimed at reversing atherosclerosis, familial hypercholesterolemias, and other conditions in which excess or modified cholesterol drives pathology.

Team

Mourad Topors, Ph.D.

Repair Biotechnologies - Chief Scientific Officer

Reason

Repair Biotechnologies - CEO

Bill Cherman

Repair Biotechnologies

Want the latest longevity news? Subscribe to our Newsletter!